Stan Berenshteyn
Stock Analyst at Wells Fargo
(0)
# 3867
Out of 5,291 analysts
63
Total ratings
40.00%
Success rate
-4.24%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GoodRx Holdings | Maintains: Overweight | 9 8 | 4.42 | 81% | 7 | Feb 28, 2025 | |
HealthEquity | Maintains: Overweight | 110 125 | 87.15 | 43.43% | 9 | Feb 26, 2025 | |
Doximity | Maintains: Equal-Weight | 43 55 | 57.59 | -4.5% | 10 | Feb 7, 2025 | |
Health Catalyst | Maintains: Overweight | 13 10 | 4.47 | 123.71% | 5 | Jan 21, 2025 | |
Omnicell | Maintains: Equal-Weight | 49 40 | 34.71 | 15.24% | 12 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 15 15 | 7.79 | 92.55% | 3 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 275 285 | 230.42 | 23.69% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | 7 | -14.29% | 10 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 28 23 | 8.05 | 185.71% | 2 | Mar 6, 2023 |